SETH SANDESH
SEC CIK 1566175 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | CEO, Dir | 1.97M | — | — | 3 | 2022-08-17 | 2026-09-02 |
Most active insiders at ATNM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chell Jeffrey W. | Dir | — | — |
| 2 | Shetty Ajit | Dir | — | — |
| 3 | Nicholson, C. David | Dir | — | — |
| 4 | SETH SANDESH | CEO, Dir | — | — |
| 5 | Almenoff June Sherie | Dir | — | — |
| 6 | Steinhart Richard I | Dir | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-04 17:00 | 2026-09-02 | ATNM | Actinium Pharmaceuticals, Inc. | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +1.78M | 1.97M | +965% | $0 |
| 2025-08-20 | 2025-08-18 | ATNM | Actinium Pharmaceuticals, Inc. | SETH SANDESH | CEO, Dir | F - Tax | $1.71 | -120.9K | 184.5K | -40% | -$206.7K | |
| 2022-08-19 | 2022-08-17 | ATNM | Actinium Pharmaceuticals, Inc. | SETH SANDESH | CEO, Dir | A - Grant | $0.00 | +300.0K | 305.4K | +5,575% | $0 |
Purchase Sale Sale after option exercise All abbreviations